Skip to main content

Table 1 Grade of malignancy (1 = low, 2 = high/intermediate), subjective view of change in symptoms between pretreatment stage (E1) and after first chemotherapy cycle (E2) (0 = unchanged, 1 = relieved).

From: Non-Hodgkin lymphoma response evaluation with MRI texture classification

Patient Grade of malignity Symptoms Volume
  1 = low
2 = high/intermediate
0 = unchanged
1 = relieved
E1 (cm3) E2 (cm3) Change%
1 2 1 429 105 -76%
2 2 1 183 64 -65%
3 1 1 173 66 -62%
4 1 1 529 459 -13%
5 1 0 570 419 -26%
6 1 1 800 595 -26%
7 2 1 146 118 -19%
8 2 0 118 80 -32%
9 1 1 367 246 -33%
10 1 0 850 769 -10%
11 2 1 2144 1622 -24%
12 2 1 72 30 -58%
13 2 0 140 52 -63%
14 2 1 274 93 -66%
15 1 1 795 190 -76%
16 1 0 824 797 -3%
17 1 0 750 579 -23%
18 1 0 273 66 -76%
19 1 0 771 522 -32%
  1. Results of the volumetric analysis of first (E1) and second imaging stages (E2). Volumes are given in cm3, and the volume change calculated in percentages.